Live from the NIH registry
Studies recruiting near Warner Robins right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Eisai Inc.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Crohn's Disease, Ulcerative Colitis
Phase 2
Interventional 2,000 participants sought
Gastroenterology Associates of Central Georgia /ID# 280464 — Macon, Georgia (16.9 mi)
· Sponsor: AbbVie
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: vTv Therapeutics
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
B-cell Lymphoma, Chronic Lymphocytic Leukemia
Phase 3
Interventional 620 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Nurix Therapeutics, Inc.
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 224 participants sought
Novartis Investigative Site — Macon, Georgia (16.9 mi)
· Sponsor: Novartis Pharmaceuticals
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Summit Therapeutics
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
The Jones Center Clinical Research — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Lung Cancer Screening, Lung Neoplasms
N/A
Interventional 80 participants sought
Pavilion Family Medicine Center — Warner Robins, Georgia (2.0 mi)
· Sponsor: University of California, Irvine
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Atrial Fibrillation
Phase 3
Interventional 5,350 participants sought
Georgia Arrhythmia Consultants and Research Institute — Warner Robins, Georgia (2.0 mi)
· Sponsor: Johns Hopkins University
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 590 participants sought
Gastroenterology Associates of Central Georgia /ID# 265547 — Macon, Georgia (16.9 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Gastroenterology Associates of Central Georgia ( Site 5048) — Macon, Georgia (16.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Non-Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Clinical Study Site — Warner Robins, Georgia (2.0 mi)
· Sponsor: Summit Therapeutics
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Skin Care Physicians Of Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
Alcohol Use Disorder (AUD)
N/A
Interventional 30 participants sought
Rescue Mission of Middle Georgia — Macon, Georgia (16.9 mi)
· Sponsor: University of Georgia
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Randomize Now-Burton Medical — Macon, Georgia (16.9 mi)
· Sponsor: Cleerly, Inc.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC